Literature DB >> 5472205

Prostaglandin uptake and metabolism by the perfused rat liver.

W Dawson, S J Jessup, W McDonald-Gibson, P W Ramwell, J E Shaw.   

Abstract

1. The prostaglandins are C20 unsaturated fatty acids which exhibit diverse physiological effects of short duration. We have investigated the speed of removal of PGE(1) and PGF(1alpha) from the circulating blood and their subsequent metabolism by the isolated perfused rat liver.2. Following either a single injection of radiolabelled PGE(1) or PGF(1alpha) into the hepatic artery or portal vein, or recirculation of prostaglandins through the liver for 2.5 h, the distribution of radioactivity within extracts of bile, blood and liver was determined. The nature of the radioactive products of meta-bolism was inferred by comparison of the distribution of radioactivity after injecting carbon and tritium labelled standards, and by thin-layer chromatography, gas-liquid chromatography, ultraviolet and bioassay analysis.3. A single injection of 1-(14)C PGE(1) indicated that the liver could efficiently remove 89-95% of circulating PGE(1) on a single passage. Biliary excretion was excluded as a major route for elimination of unchanged PGE(1), because only 0.3-0.8% of the injected radioactivity was detected in the bile. During recirculation of 1-(14)C PGE(1), 11-19% of the injected radioactivity was detected as exchanged (14)CO(2). The radioactivity detected within liver was identified with further fragments resulting from decarboxylation of PGE(1), which were incorporated into fatty acids and then phospholipids.4. Studies with 5,6-(3)H PGE(1), and comparison with the results obtained using 1-(14)C PGE(1), revealed a 30-fold increase in the percentage of radioactivity excreted into the bile, suggesting that biliary excretion may be a major route for elimination of compounds smaller than C20 prostaglandin. Evidence that the cyclopentane ring was intact was inferred by formation of a PGB compound on treatment with alkali; similar biliary excretion of 9-(3)H PGF(1alpha) also occurred. In addition, the increased radioactivity detected within the liver (37%) and blood (43%) after a single injection of 5,6-(3)H PGE(1) had the solvent partition and thin-layer chromatography properties of PGE(1), but were associated with a less polar compound smaller than the C20 parent structure.5. These results indicate rapid uptake of circulating prostaglandins by the rat liver. Decarboxylation of prostaglandins results in pharmacological inactivation. The products are excreted into the bile and venous effluent. These processes would curtail the duration of effects following prostaglandin injection.In addition, we infer from these results that any physiological action of these ubiquitous endogenous substances is likely to be localized within their tissue of origin.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5472205      PMCID: PMC1702617          DOI: 10.1111/j.1476-5381.1970.tb10366.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea.

Authors:  E D Williams; S M Karim; M Sandler
Journal:  Lancet       Date:  1968-01-06       Impact factor: 79.321

2.  Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation.

Authors:  J E Shaw; P W Ramwell
Journal:  J Biol Chem       Date:  1968-04-10       Impact factor: 5.157

3.  Quantitative analysis of phospholipids by thin-layer chromatography.

Authors:  V P Skipski; R F Peterson; M Barclay
Journal:  Biochem J       Date:  1964-02       Impact factor: 3.857

4.  The occurrence of prostaglandin E2 in splenic venous blood of the dog following splenic nerve stimulation.

Authors:  B N Davies; E W Horton; P G Withrington
Journal:  Br J Pharmacol Chemother       Date:  1968-01

5.  Observations on the extraction of prostaglandins from blood.

Authors:  S W Holmes; E W Horton; M J Stewart
Journal:  Life Sci       Date:  1968-04-15       Impact factor: 5.037

6.  Lysosomal changes associated with hyperoxia in the isolated perfused rat liver.

Authors:  R Abraham; W Dawson; P Grasso; L Golberg
Journal:  Exp Mol Pathol       Date:  1968-06       Impact factor: 3.362

7.  Complete separation of lipid classes on a single thin-layer plate.

Authors:  C P Freeman; D West
Journal:  J Lipid Res       Date:  1966-03       Impact factor: 5.922

8.  The biological activities of three metabolites of prostaglandin E 1.

Authors:  E Anggård
Journal:  Acta Physiol Scand       Date:  1966-04

9.  Autoradiographic distribution studies of 3H-labeled prostaglandin E1 in mice. Prostaglandins and related factors 31.

Authors:  E Hansson; B Samuelsson
Journal:  Biochim Biophys Acta       Date:  1965-10-04

10.  Prostaglandins: their disappearance from and release into the circulation.

Authors:  S H Ferreira; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

View more
  10 in total

1.  Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin E2 in the perfused rat liver.

Authors:  D B Buxton; R A Fisher; D L Briseno; D J Hanahan; M S Olson
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 2.  [Regulation of liver functions by autonomic hepatic nerves].

Authors:  K Jungermann
Journal:  Naturwissenschaften       Date:  1989-12

Review 3.  Prostaglandins and the gastrointestinal tract.

Authors:  S L Waller
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

4.  Stimulation of water and sodium secretion and inhibition of glucose absorption from the rat jejunum during intraarterial infusions of prostglandins.

Authors:  I M Coupar; I McColl
Journal:  Gut       Date:  1975-10       Impact factor: 23.059

5.  Prostaglandins E2 and F2 alpha affect glycogen synthase and phosphorylase in isolated hepatocytes.

Authors:  A M Gómez-Foix; J E Rodriguez-Gil; J J Guinovart; F Bosch
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

6.  Prostaglandin E1 enhances hepatic portal venous flow by dilating the portal vascular bed in 70% hepatectomized dog.

Authors:  K Tsukada; H Katoh; Y Iga; T Tomiyama; N Okamura; F Sugimoto; T Ohtani; T Iiai; T Sakaguchi; K Yoshida
Journal:  Gastroenterol Jpn       Date:  1992-06

7.  A pharmacological analysis of prostaglandin E1 on portal blood flow after partial hepatectomy in rats.

Authors:  K Nakadaira; K Tsukada; T Sakaguchi; Y Shirai; I Kurosaki; M Ohtake; K Yoshida; T Muto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Enhanced hepatic portal blood flow induced by prostaglandin E1 following liver transplantation in pigs.

Authors:  K Tsukada; T Sakaguchi; T Tomiyama; K Uchida; Y Sato; T Tsubono; M Ohtake; S Koyama; T Aono; K Hatakeyama
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

9.  Accumulation and apparent active transport of prostaglandins by some rabbit tissues in vitro.

Authors:  L Z Bito
Journal:  J Physiol       Date:  1972-03       Impact factor: 5.182

10.  Effect of prostaglandins on hepatic cyclic nucleotide concentration, carbohydrate and lipid metabolism.

Authors:  R A Levine
Journal:  Yale J Biol Med       Date:  1979 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.